Lykan Bioscience is a contract development and manufacturing services organization (CDMO) focused on cell-based therapies. With decades of biopharmaceutical industry experience, Lykan offers a full range of development and manufacturing services. The state-of-the-art, purpose-built facility offering eight independent manufacturing suites is uniquely designed to fully integrate cGMP principles and advanced software solutions to enable real-time testing and release of product. Located in Hopkinton, Massachusetts, 25 miles southwest of downtown Boston and in the proximity of three international airports, Lykan Bioscience is ideally situated to deliver life-saving cell therapy treatments to patients on behalf of their partners.
Location: United States, Massachusetts, Hopkinton
Employees: 51-200
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | WindRose H... | windrose.c... |
Mentions in press and media 3
| Date | Title | Description |
| 22.11.2021 | Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO | Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focuses on the research, development and commercialization of TCM for the treatment of neurocognitive disorders and degene... |
| 16.07.2021 | Regencell Bioscience Holdings Limited : Announces Pricing of Approximately $21.9 Million Initial Public Offering | Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (“TCM”) for the treatment of ne... |
| 04.06.2019 | Inside the Secrets of Sand Hill Road: Term Sheet | 5 Qs WITH A DEALMAKER Scott Kupor has been at Andreessen Horowitz since the venture capital firm launched in 2009. As managing partner, he has overseen the firm’s growth to 150 employees and more than $7 billion in assets under management. ... |